Articles published by Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics Announces Positive Primary Vitreoretinal Lymphoma Pre-NDA Meeting with the FDA
December 01, 2022
Via Business Wire
Tickers
ALDX
Aldeyra Therapeutics Reports Third-Quarter 2022 Financial Results and Recent Corporate Highlights
November 10, 2022
Via Business Wire
Tickers
ALDX
Aldeyra Therapeutics to Participate in Upcoming Investor Conferences
September 07, 2022
Via Business Wire
Tickers
ALDX
Aldeyra Therapeutics Reports Second-Quarter 2022 Financial Results and Recent Corporate Highlights
August 05, 2022
Via Business Wire
Tickers
ALDX
Via Business Wire
Tickers
ALDX
Via Business Wire
Tickers
ALDX
Via Business Wire
Tickers
ALDX
Via Business Wire
Tickers
ALDX
Via Business Wire
Tickers
ALDX
Aldeyra Therapeutics Announces Publication of Phase 2 Clinical Trial of Reproxalap in Allergen Chamber Model
February 01, 2022
Via Business Wire
Tickers
ALDX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.